According to campaign for sustainable prescription drug pricing between 2017 and 2018 pharmaceutical companies more than doubled shareholder dividends while investing only 6 percent more in research and development.
Ilhan Omar: “According to campaign for sustainable prescription drug pricing between 2017 and 2018 pharmaceutical companies more than…”
On the recordJune 15, 2021
Source
congress.govEditor's note · Context
Omar highlights the disparity in pharmaceutical investment versus shareholder profits.
Share
More from Ilhan Omar
Oct 17, 2026
The Congresswoman has done nothing wrong. No president should be able to use the power of the federal government to intimidate his political enemies.
Oct 14, 2026
I’m ok. Make no mistake: this is an attempt to target political enemies and weaponize federal law enforcement. For ten years, Trump has targeted me with baseless lies and smear campaigns. This is just the latest escalation in his campaign…
Oct 13, 2026
Make no mistake: this is an attempt to target political enemies and weaponize federal law enforcement.
Oct 16, 2026
It is an unprecedented escalation in the weaponization of federal law enforcement to target political enemies.





